James Nelson's most recent trade in Chewy Inc - Ordinary Shares - Class A was a trade of 10,665 Class A Common Stock done . Disclosure was reported to the exchange on July 9, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Chewy Inc (Class A) | James L. Nelson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 10,665 | 10,665 (0%) | 0% | 0 | Class A Common Stock | |
| Co-Diagnostics Inc | James Nelson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 May 2026 | 1,695 | 4,000 | - | - | Restricted Stock Unit | |
| Co-Diagnostics Inc | James Nelson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2026 | 1,695 | 10,668 (0%) | 0% | 0 | Common Stock | |
| EagleRock Land LLC Ordinary | James C. Nelson | Director | Purchase of securities on an exchange or from another person at price $ 18.50 per share. | 15 May 2026 | 50,000 | 50,000 | - | 18.5 | 925,000 | Class A shares |
| EagleRock Land LLC Ordinary | James C. Nelson | Director | Purchase of securities on an exchange or from another person at price $ 18.50 per share. | 15 May 2026 | 50,000 | 50,000 | - | 18.5 | 925,000 | Class A shares |
| Co-Diagnostics Inc | James Nelson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Nov 2025 | 57,499 | 170,834 | - | - | Restricted Stock Unit | |
| Co-Diagnostics Inc | James Nelson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Nov 2025 | 57,499 | 269,166 (1%) | 0% | 0 | Common Stock | |
| Co-Diagnostics Inc | James Nelson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2025 | 125,000 | 228,333 | - | - | Restricted Stock Units | |
| Chewy Inc (Class A) | James L. Nelson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 4,921 | 4,921 (0%) | 0% | 0 | Class A Common Stock | |
| Co-Diagnostics Inc | James Nelson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 May 2025 | 48,334 | 103,333 | - | - | Restricted Stock Unit | |
| Co-Diagnostics Inc | James Nelson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2025 | 48,334 | 211,667 (0%) | 0% | 0 | Common Stock | |
| Co-Diagnostics Inc | James Nelson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Nov 2024 | 48,333 | 163,333 (0%) | 0% | 0 | Common Stock | |
| Co-Diagnostics Inc | James Nelson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Nov 2024 | 48,333 | 151,667 | - | - | Restricted Stock Unit | |
| Chewy Inc (Class A) | James L. Nelson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2024 | 8,133 | 8,133 (0%) | 0% | 0 | Class A Common Stock | |
| Co-Diagnostics Inc | James Nelson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 30,000 | 115,000 (0%) | 0% | 0 | Common Stock | |
| Co-Diagnostics Inc | James Nelson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 May 2024 | 30,000 | 200,000 | - | - | Restricted Stock Unit | |
| Co-Diagnostics Inc | James Nelson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2024 | 110,000 | 230,000 | - | - | Restricted Stock Units | |
| Global Net Lease Inc | James L. Nelson | Director, Co-CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.22 per share. | 18 Sep 2023 | 1,286 | 69,993 (0%) | 0% | 11.2 | 14,429 | Common Stock |
| Chewy Inc (Class A) | James L. Nelson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2023 | 4,880 | 4,880 (0%) | 0% | 0 | Class A Common Stock | |
| Co-Diagnostics Inc | James Nelson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2023 | 70,000 | 150,000 | - | - | Restricted Stock Units | |
| Co-Diagnostics Inc | James Nelson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 May 2023 | 18,333 | 80,000 | - | - | Restricted Stock Units | |
| Co-Diagnostics Inc | James Nelson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2023 | 18,333 | 55,000 (0%) | 0% | 0 | Common Stock | |
| Xerox Holdings Corp | James L. Nelson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2023 | 30,576 | 30,576 | - | - | Restricted Stock Units | |
| Xerox Holdings Corp | James L. Nelson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 May 2023 | 24,899 | 37,677 (0%) | 0% | - | Common Stock | |
| Xerox Holdings Corp | James L. Nelson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 May 2023 | 24,899 | 0 | - | - | Restricted Stock Units | |
| Global Net Lease Inc | James L. Nelson | CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.09 per share. | 03 May 2023 | 1,597 | 71,279 (0%) | 0% | 11.1 | 17,711 | Common Stock |
| Co-Diagnostics Inc | James Nelson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 40,000 | 98,333 | - | - | Restricted Stock Units | |
| Co-Diagnostics Inc | James Nelson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jan 2023 | 12,500 | 58,333 | - | - | Restricted Stock Units | |
| Co-Diagnostics Inc | James Nelson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jan 2023 | 12,500 | 36,667 (0%) | 0% | 0 | Common Stock | |
| Co-Diagnostics Inc | James Nelson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Nov 2022 | 11,667 | 70,833 | - | - | Restricted Stock Units | |
| Co-Diagnostics Inc | James Nelson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Nov 2022 | 11,667 | 24,167 (0%) | 0% | 0 | Common Stock | |
| Chewy Inc (Class A) | James L. Nelson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2022 | 5,145 | 5,145 (0%) | 0% | 0 | Class A Common Stock | |
| Co-Diagnostics Inc | James Nelson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2022 | 70,000 | 82,500 | - | - | Restricted Stock Units | |
| Xerox Holdings Corp | James L. Nelson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2022 | 24,899 | 37,677 | - | 0 | Restricted Stock Units | |
| Xerox Holdings Corp | James L. Nelson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 May 2022 | 12,778 | 24,899 | - | 0 | Restricted Stock Units | |
| Xerox Holdings Corp | James L. Nelson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 May 2022 | 12,778 | 12,778 (0%) | 0% | 0 | Common Stock | |
| Global Net Lease Inc | James L. Nelson | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.87 per share. | 10 May 2022 | 13,745 | 74,283 (0%) | 0% | 12.9 | 176,898 | Common Stock |
| Global Net Lease Inc | James L. Nelson | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2022 | 35,100 | 88,028 (0%) | 0% | 0 | Common Stock | |
| Global Net Lease Inc | James L. Nelson | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.78 per share. | 03 May 2022 | 1,597 | 52,928 (0%) | 0% | 13.8 | 22,007 | Common Stock |
| Xerox Holdings Corp | James L. Nelson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2022 | 149 | 12,778 | - | 0 | Restricted Stock Units | |
| Co-Diagnostics Inc | James Nelson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jan 2022 | 12,500 | 12,500 | - | - | Restricted Stock Units | |
| Co-Diagnostics Inc | James Nelson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jan 2022 | 12,500 | 12,500 (0%) | 0% | 0 | Common Stock |